These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 36369945)
1. Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening. Esther Rubavathy SM; Palanisamy K; Priyankha S; Thilagavathi R; Prakash M; Selvam C J Biomol Struct Dyn; 2023 Nov; 41(19):9492-9502. PubMed ID: 36369945 [TBL] [Abstract][Full Text] [Related]
2. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents. Dewaker V; Srivastava AK; Arora A; Prabhakar YS J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation. Debnath S; Debnath T; Bhaumik S; Majumdar S; Kalle AM; Aparna V Sci Rep; 2019 Nov; 9(1):17174. PubMed ID: 31748509 [TBL] [Abstract][Full Text] [Related]
4. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies. Kashyap K; Kakkar R J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630 [TBL] [Abstract][Full Text] [Related]
5. Dynamic structure-based pharmacophore model development: a new and effective addition in the histone deacetylase 8 (HDAC8) inhibitor discovery. Thangapandian S; John S; Lee Y; Kim S; Lee KW Int J Mol Sci; 2011; 12(12):9440-62. PubMed ID: 22272142 [TBL] [Abstract][Full Text] [Related]
11. Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation. Uba AI; Weako J; Keskin Ö; Gürsoy A; Yelekçi K J Biomol Struct Dyn; 2020 Apr; 38(6):1751-1760. PubMed ID: 31057077 [TBL] [Abstract][Full Text] [Related]
12. Virtual discovery of a hetero-cyclic compound from the Universal Natural Product Database (UNPD36) as a potential inhibitor of interleukin-33: molecular docking and dynamic simulations. Adamu RM; Singh RM; Ibrahim MA; Uba AI J Biomol Struct Dyn; 2022; 40(19):8696-8705. PubMed ID: 33896389 [TBL] [Abstract][Full Text] [Related]
13. The Importance of Structural Water in HDAC8 for Correct Binding Pose Applied for Drug Design of Anticancer Molecules. Morales-Herrejón G; Mendoza-Figueroa HL; Martínez-Archundía M; Correa-Basurto J Anticancer Agents Med Chem; 2024; 24(15):1109-1125. PubMed ID: 38835122 [TBL] [Abstract][Full Text] [Related]
14. A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors. Hassanzadeh M; Bagherzadeh K; Amanlou M J Mol Graph Model; 2016 Nov; 70():170-180. PubMed ID: 27750186 [TBL] [Abstract][Full Text] [Related]
15. Exploring the potential of Das D; Banerjee R; Bandyopadhyay M; Nag A J Biomol Struct Dyn; 2023 Nov; ():1-13. PubMed ID: 37969010 [TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors. Sulaiman KO; Kolapo TU; Onawole AT; Islam MA; Adegoke RO; Badmus SO J Biomol Struct Dyn; 2019 Aug; 37(12):3029-3040. PubMed ID: 30058446 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay. Uba AI; Yelekçi K J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863 [TBL] [Abstract][Full Text] [Related]
18. A lazy learning-based QSAR classification study for screening potential histone deacetylase 8 (HDAC8) inhibitors. Cao GP; Arooj M; Thangapandian S; Park C; Arulalapperumal V; Kim Y; Kwon YJ; Kim HH; Suh JK; Lee KW SAR QSAR Environ Res; 2015; 26(5):397-420. PubMed ID: 25986171 [TBL] [Abstract][Full Text] [Related]